Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Artiva Biotherapeutics (ARTV) Leases (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Leases for 3 consecutive years, with $212000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Leases fell 98.46% to $212000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $212000.0, a 98.46% decrease, with the full-year FY2025 number at $212000.0, down 98.46% from a year prior.
  • Leases was $212000.0 for Q4 2025 at Artiva Biotherapeutics, down from $11.3 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $16.5 million in Q4 2023 to a low of $212000.0 in Q4 2025.
  • A 3-year average of $10.4 million and a median of $13.1 million in 2025 define the central range for Leases.
  • Biggest YoY gain for Leases was 3980.43% in 2025; the steepest drop was 98.46% in 2025.
  • Artiva Biotherapeutics' Leases stood at $16.5 million in 2023, then fell by 16.64% to $13.8 million in 2024, then plummeted by 98.46% to $212000.0 in 2025.
  • Per Business Quant, the three most recent readings for ARTV's Leases are $212000.0 (Q4 2025), $11.3 million (Q3 2025), and $12.7 million (Q2 2025).